Results 261 to 270 of about 582,852 (293)
Some of the next articles are maybe not open access.
The therapeutic potential of novel phosphate binders
Pediatric Nephrology, 2005Hyperphosphatemia and an increased serum calcium-phosphate (CaxP) product are associated with cardiovascular mortality in adult dialysis patients. Target levels for the treatment of elevations in serum phosphorus (P) and the CaxP product have recently been redefined, but are difficult to achieve in clinical practice.
openaire +2 more sources
Phosphate binders in refractories for steelcasting
Refractories, 1975Nozzles for steelcasting are more durable when produced with an aluminochromophosphate binder than with an aluminophosphate binder, the reasons being the more favorable conditions for the preparation of the batch and the state of the bond during firing and in the steelcasting process. Nozzles containing ACPB No.
G. �. Solovushkova +5 more
openaire +1 more source
Medizinische Monatsschrift fur Pharmazeuten, 2016
Phosphate binders to treat hyperphosphataemia are part of the medication regime of every dialysis patient. Phosphate binders are taken with every meal (three times a day). Generally, the medication adherence rates of phosphate binders are very low. This is due to inconveniences like their bad taste or their size which makes them hard to swallow.
openaire +1 more source
Phosphate binders to treat hyperphosphataemia are part of the medication regime of every dialysis patient. Phosphate binders are taken with every meal (three times a day). Generally, the medication adherence rates of phosphate binders are very low. This is due to inconveniences like their bad taste or their size which makes them hard to swallow.
openaire +1 more source
An Update on Phosphate Binders: A Dietitian's Perspective
Journal of Renal Nutrition, 2016Control of serum phosphorus (PO4) has been long recognized as a goal in the nutritional and medical management of the patients with chronic kidney disease. Phosphate-binding compounds were introduced in the 1970s for the treatment of hyperphosphatemia in patients on dialysis after it was observed that oral administration of aluminum hydroxide as an ...
openaire +2 more sources
Up-to-date on phosphate management and phosphate binders
Journal of Kidney Care, 2019Although the cause of hyperphosphatemia remains the same, its management through dietary advice and medication is changing to keep up with the latest evidence.
openaire +2 more sources